138 related articles for article (PubMed ID: 11815977)
1. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas.
Porter GA; Cantor SB; Ahmad SA; Lenert JT; Ballo MT; Hunt KK; Feig BW; Patel SR; Benjamin RS; Pollock RE; Pisters PW
Cancer; 2002 Jan; 94(1):197-204. PubMed ID: 11815977
[TBL] [Abstract][Full Text] [Related]
2. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas.
Fleming JB; Cantor SB; Varma DG; Holst D; Feig BW; Hunt KK; Patel SR; Benjamin RS; Pollock RE; Pisters PW
Cancer; 2001 Aug; 92(4):863-8. PubMed ID: 11550159
[TBL] [Abstract][Full Text] [Related]
3. Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas.
Christie-Large M; James SL; Tiessen L; Davies AM; Grimer RJ
Eur J Cancer; 2008 Sep; 44(13):1841-5. PubMed ID: 18640829
[TBL] [Abstract][Full Text] [Related]
4. The value of re-staging chest CT at first local recurrence of extremity and trunk soft tissue sarcoma.
Baig MS; Habib W; Attard V; Sharif B; Lindsay D; Upadhyay B; Saifuddin A
Eur Radiol; 2021 Apr; 31(4):2377-2383. PubMed ID: 33037910
[TBL] [Abstract][Full Text] [Related]
5. Effective utilization of chest X-ray for follow-up of metastatic lung tumor due to soft tissue sarcoma.
Shikada Y; Yano T; Maruyama R; Takenoyama M; Maehara Y
Ann Thorac Cardiovasc Surg; 2013; 19(2):103-6. PubMed ID: 22971713
[TBL] [Abstract][Full Text] [Related]
6. Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?
Gamboa AC; Ethun CG; Switchenko JM; Lipscomb J; Poultsides GA; Grignol V; Howard JH; Gamblin TC; Roggin KK; Votanopoulos K; Fields RC; Maithel SK; Delman KA; Cardona K
J Am Coll Surg; 2019 Nov; 229(5):449-457. PubMed ID: 31377411
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma.
Royce TJ; Punglia RS; Chen AB; Patel SA; Thornton KA; Raut CP; Baldini EH
Ann Surg Oncol; 2017 Oct; 24(11):3264-3270. PubMed ID: 28718037
[TBL] [Abstract][Full Text] [Related]
8. Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan.
Kosuda S; Ichihara K; Watanabe M; Kobayashi H; Kusano S
Chest; 2000 Feb; 117(2):346-53. PubMed ID: 10669673
[TBL] [Abstract][Full Text] [Related]
9. A review of staging chest CT in trunk and extremity soft tissue sarcoma.
Saifuddin A; Shafiq H; Rajakulasingam R; Tan A; O'Donnell P; Khoo M
Br J Radiol; 2021 Feb; 94(1118):20201109. PubMed ID: 33237819
[TBL] [Abstract][Full Text] [Related]
10. What Is the Clinical Importance of Incidental Findings on Staging CT Scans in Patients With Sarcoma?
Mayo Z; Kennedy S; Gao Y; Miller BJ
Clin Orthop Relat Res; 2019 Apr; 477(4):730-737. PubMed ID: 30601764
[TBL] [Abstract][Full Text] [Related]
11. CT scans for pulmonary surveillance may be overused in lower-grade sarcoma.
Miller BJ; Carmody Soni EE; Reith JD; Gibbs CP; Scarborough MT
Iowa Orthop J; 2012; 32():28-34. PubMed ID: 23576918
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of computed tomography for monitoring pulmonary metastases in soft tissue sarcoma patients after surgical management: a retrospective cohort study.
Cho HS; Park IH; Jeong WJ; Han I; Kim HS
Ann Surg Oncol; 2011 Nov; 18(12):3392-8. PubMed ID: 21537873
[TBL] [Abstract][Full Text] [Related]
13. Routine bone scintigraphy in primary staging of soft tissue sarcoma; Is it worthwhile?
Jager PL; Hoekstra HJ; Leeuw J; van Der Graaf WT; de Vries EG; Piers D
Cancer; 2000 Oct; 89(8):1726-31. PubMed ID: 11042567
[TBL] [Abstract][Full Text] [Related]
14. Radiographic evaluation for pulmonary metastases in sarcoma patients.
Duda RB; Beatty JD; Kokal WA; Riihimaki DU; Terz JJ
J Surg Oncol; 1988 Aug; 38(4):271-4. PubMed ID: 3411970
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and cost-effectiveness of alternative staging strategies for non-small-cell lung cancer.
Esnaola NF; Lazarides SN; Mentzer SJ; Kuntz KM
J Clin Oncol; 2002 Jan; 20(1):263-73. PubMed ID: 11773178
[TBL] [Abstract][Full Text] [Related]
16. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of chest CT in T1N0M0 lung cancer.
Black WC; Armstrong P; Daniel TM
Radiology; 1988 May; 167(2):373-8. PubMed ID: 3128840
[TBL] [Abstract][Full Text] [Related]
18. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of positron emission tomography for the management of potentially operable non-small cell lung cancer in Quebec.
Nguyen VH; Peloquin S; Lacasse Y
Can Respir J; 2005; 12(1):19-25. PubMed ID: 15776130
[TBL] [Abstract][Full Text] [Related]
20. The Surveillance After Extremity Tumor Surgery (SAFETY) trial: protocol for a pilot study to determine the feasibility of a multi-centre randomised controlled trial.
SAFETY Investigators
BMJ Open; 2019 Sep; 9(9):e029054. PubMed ID: 31537562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
